Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
about
Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A₂A receptor levels in rats subjected to neuroinflammation.Chronic caffeine ingestion causes microglia activation, but not proliferation in the healthy brainRole of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice.Differential rescue of spatial memory deficits in aged rats by L-type voltage-dependent calcium channel and ryanodine receptor antagonism.Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's diseaseCaffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma.Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia.Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.Differential Effect of Caffeine Consumption on Diverse Brain Areas of Pregnant Rats.Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease.Riluzole partially rescues age-associated, but not LPS-induced, loss of glutamate transporters and spatial memory.Time-Dependent Compensatory Responses to Chronic Neuroinflammation in Hippocampus and Brainstem: The Potential Role of Glutamate NeurotransmissionNeurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.Cocoa phytochemicals: recent advances in molecular mechanisms on health.Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.Effect of Paullinia cupana Mart. Commercial Extract During the Aging of Middle Age Wistar Rats: Differential Effects on the Hippocampus and Striatum.Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone.Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.Sodium thiosulphate attenuates brain inflammation induced by systemic lipopolysaccharide administration in C57BL/6J mice.Behavioral and pathophysiological outcomes associated with caffeine consumption and repetitive mild traumatic brain injury (RmTBI) in adolescent rats.Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage.Caffeine Neuroprotective Mechanism Against β-Amyloid Neurotoxicity in SHSY5Y Cell Line: Involvement of Adenosine, Ryanodine, and N-Methyl-D-Aspartate Receptors.Caffeine and Modafinil Ameliorate the Neuroinflammation and Anxious Behavior in Rats during Sleep Deprivation by Inhibiting the Microglia Activation.Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview.Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction.Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.
P2860
Q33730081-94C3A004-0054-4676-9795-CADB184DDD5DQ33954408-FA9B65A9-1938-4D70-A73D-93B1690B4D9DQ34014053-629C74C9-0406-4CC8-B892-F4ABDEF18142Q34238362-74D087F9-DDC2-4E83-BF74-180331FD066CQ34603211-F1BBA578-31C1-41DD-8A96-7A540D50375AQ35489240-73DADBD4-9A6B-482D-A271-6967B38C686DQ35830757-2FD5E215-E373-4412-BA12-FDB2CB005457Q36043139-A3F7650F-1C22-4920-90C8-F37617991D35Q36597141-090CFEBD-DA28-478D-BE1A-0849F6AB38E6Q36723079-C8A21F0D-F5CD-42E6-B1E2-352A66BF149FQ36752691-C62EAD25-A62C-4681-B9ED-9833116ED1A4Q36882447-BE0B03FC-2C8F-4C80-84F1-4AB960860F46Q37227856-D361F91A-8F2E-4BD5-BCD5-4482901C8FBDQ37612310-0EA2AF55-23B2-4533-B58A-7FFB37E3D644Q38118901-FA2590DD-2A7E-4698-89B1-F78B52C9157DQ38192076-A65758CE-EEE0-4067-88F4-F7EB45DACBB2Q38538932-E522F8FF-8BA4-4DF0-B746-FB994B99A4F3Q38874855-3EAC67AD-6656-4134-A8BC-5EE4A74A4972Q38903349-000A1756-103D-4435-BC31-35DCB81BF4E4Q39157059-D0259583-FC19-41F7-AFEA-221E517F8E80Q40205263-7E7FDF3D-8CDF-4E6D-91BF-3FF9BD467CAEQ47099714-AD8426FE-4260-4AD6-B352-F2FCB1AC0F5FQ47387315-CBE51923-03C5-4EA9-B17C-3B26356EFAC2Q49182621-8E47484A-5F1E-4B18-A166-9FB454FDFB45Q52620604-AFD407E9-D631-4D01-B7F7-F9026E69FE84Q54572410-8F084DF9-AB79-4790-A80A-DE4826338D08Q54620115-66CB35D9-C442-4811-A351-330D581C313EQ55132660-75F6485E-6E07-4E46-9EFC-51238DAA73CC
P2860
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
@ast
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
@en
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
@nl
type
label
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
@ast
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
@en
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
@nl
prefLabel
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
@ast
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
@en
Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
@nl
P2860
P1433
P1476
Caffeine attenuates lipopolysaccharide-induced neuroinflammation
@en
P2093
Gary L Wenk
Yannick Marchalant
P2860
P304
P356
10.1016/J.NEULET.2010.06.013
P407
P577
2010-06-10T00:00:00Z